BrainJuicer Group PLC
05 December 2006
Press Release 05 December 2006
BrainJuicer plc
('BrainJuicer' or 'the Company')
First day of dealings on AiM
BrainJuicer Group PLC, one of Europe's leading online market research agencies,
today announces the commencement of dealings of its Ordinary Shares on the AiM
Market of the London Stock Exchange. Teather & Greenwood Landsbanki is the
Company's Nominated Adviser and Broker. The stock market EPIC is BJU.
UK based BrainJuicer was established in 1999 to provide quantitative online
research using innovative, bespoke software to produce insightful market
research for large multinational companies. BrainJuicer has over 80 clients,
including 10 of the world's top 50 companies (FT 500, September 2006) and is
regarded as one of the leading innovators in the research industry. The Company
is focused on assisting clients throughout their development process by
providing rich diagnostics to enable clients to better understand consumers and
then identify the strongest product, pack and advertising ideas and how best to
develop them. The Board's objective is to position the Company as an
international market-leading research agency.
Placing and Admission Statistics
Placing Price 108p
Number of New Ordinary Shares to be issued pursuant to the Placing 1,388,900
Number of Ordinary Shares in issue immediately following Admission 12,550,613
Percentage of the Company's enlarged issued share capital being placed 11.07 per cent.
Market capitalisation of the Company at the Placing Price £13.55 million
Gross proceeds of the Placing available to the Company £1.50 million
Estimated net proceeds of the Placing receivable by the Company £1.01 million
John Kearon, Chairman and Chief Executive of BrainJuicer, commented: 'We are
pleased that the flotation has been successfully completed and are delighted
with the support received from our new shareholders. BrainJuicer is one of the
first companies to make full use of the Internet's interactive capabilities,
adding deep qualitative understanding to robust quantitative research and
reducing research timescales.
'The Company's innovative research methodology and bespoke software positions
BrainJuicer favourably to tap into the fast growing sector of online market
research. The Company aims to remain at the forefront of market research through
developing innovative research techniques to drive the business forward. We
look forward to continued growth.'
- Ends -
For further information, please contact:
BrainJuicer plc
John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000
www.brainjuicer.com
Teather & Greenwood Landsbanki
James Maxwell / Fred Walsh / Simon Brown Tel: +44 (0)20 7426 9000
www.teathers.com
Media enquiries:
Abchurch Communications
Heather Salmond / Leena Patel Tel: +44 (0) 20 7398 7704 /
+44 (0) 20 7398 7711
Heather.salmond@abchurch-group.com www.abchurch-group.com
Photography
Photographs are available from Abchurch. To arrange to receive soft copies,
please contact Leena Patel on 020 7398 7711 or leena.patel@abchurch-group.com
Notes for editors
BrainJuicer carries out quantitative online research using innovative, bespoke
software to produce insightful market research for large, multinational
companies, including 10 of the world's top 50 companies (FT 500 September 2006).
BrainJuicer operates in a growing sector of the US$23bn global research market,
namely quantitative online research. BrainJuicer's main competitors are large
traditional market research providers who have dominated the market for off-line
market research, such as AC Nielsen, Millward Brown, Research International and
Taylor Nelson Sofres.
Whilst the largest traditional research companies have developed their own
online capability, BrainJuicer has a number of key attributes which have
contributed to it achieving rapid growth and winning contracts with prestigious
clients, including:
• A scaleable online-only business model. Unlike the traditional research
companies who maintain both on and offline data collection capabilities,
BrainJuicer is able to focus on operating a scaleable online-only business
model.
• Research platform that delivers greater diagnostic insight. BrainJuicer has
developed tools and award-winning techniques that enable it to provide a greater
level of diagnostic insight into quantitative market research. These techniques
enable clients to enhance their understanding of consumer preference and help
them make decisions on the best way to develop their products and services.
• Speed. BrainJuicer's automated research techniques enable it to conduct
complicated studies very quickly. BrainJuicer's rapid deployment and results
production, even on multi-country studies, provide clients with a speed to
market advantage in the development of new products and services.
To date the Group has conducted projects in over 50 countries and more than 30
languages and has established offices in the UK, the Netherlands and the US.
The Group's revenues come from full service market research work, and from its
online Juicy Brains Panel in the UK.
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.